Investing.com– CVS Health Corp (NYSE:CVS) plans to separate its retail pharmacy business from its insurance operations, potentially undoing one of the largest vertical integration deals in the U.S. healthcare industry, the Financial Times reported on Tuesday, citing people familiar with the matter. Still guessing which stocks will outperform the market? Our AI portfolio is updated monthly and outperforms the S&P 500 by 118%. See this month’s list » Under plans being discussed, CVS would spin off its roughly 9,000 pharmacies into a separate publicly traded company, while insurer Aetna and pharmacy benefits manager Caremark would remain together, according to the report. Not sure what to buy before earnings? Our AI’s recent pre-earnings calls generated gains of +77% to +118% after earnings fell. See this month’s earnings picks » The retail pharmacy division is projected to generate about a third of CVS’s $417 billion in revenue this year, the Financial Times reported. The proposed restructuring would reverse CVS’s $78 billion acquisition of Aetna in 2018, amid growing political pressure to separate pharmacy benefit managers from pharmacies and insurers. The company could announce the move alongside its third-quarter results, although the structure and timeline remain subject to change, according to the report. Original article CVS Health to split into two publicly traded companies by 2028, FT reports Super Micro Computer rises 6% as earnings and top estimates Asian stocks trim declines as US election uncertainty eases
